Compounds represented by the general formula (1) or salts thereof or solvates of both； PAR-2 antagonists containing the compounds； and preventive or therapeutic agents for PAR-2 related diseases containing the antagonists as the active ingredient: (1) wherein R1 is hydrogen, halogeno, or a group represented by the general formula (2): (wherein R11 is straight-chain or branched C1-6 alkylene or the like； and R12 and R13 together with the nitrogen atom adjacent to them form a 5- to 7-membered ring)； R2 is straight-chain or branched C1-6 alkyl or the like； R3 and R4 are each independently hydrogen, one to three halogen atoms, or the like； and A1-A2-A3 is a tripeptide residue composed of α-amino acids each independently selected from the group consisting of glycine, alanine, cyclohexylalanine, and so on.
